Picture of BIO-TECHNE logo

TECH — BIO-TECHNE Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-21.1%
3m-27.11%
6m-23.57%
1yr-11.2%
Volume Change (%)
10d/3m+46.1%
Price vs... (%)
52w High-30.31%
50d MA-19.74%
200d MA-18.46%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)44.36
PEG Ratio (f)1.52
EPS Growth (f)41.21%
Dividend Yield (f)0.34%
Valuation (ttm)IndustryMarket
Price to Book Value9.08
Price to Tang. Book73.35
Price to Free Cashflow50.46
Price to Sales15.13
EV to EBITDA43.65

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11.77%
Return on Equity11.47%
Operating Margin25.54%

Financial Summary

Year End 30th JunUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m563642.99714.01738.69931.031,090.961,247.3513.28%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-13.64+28.39-12.27+97.43-35.14+115.77+13.64n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for TECH

Where next for the Bio-techne share price? background image

Where next for the Bio-techne share price?

Shares in Bio-techne (NSQ:TECH) are currently trading at 245.73 but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price. The answer comes down to judging whether Bio-techne is well plac...

The Bio-techne share price – where next? background image

The Bio-techne share price – where next?

The Bio-techne (NSQ:TECH) share price has risen by 23.2% over the past month and it’s currently trading at 258.4. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continu...

Bio-techne (NSQ:TECH): buy, sell or hold? background image

Bio-techne (NSQ:TECH): buy, sell or hold?

Shares in Bio-techne (NSQ:TECH) are currently trading close to a 52 week high, with the share price up by around 13.3% - to 246.06 - over the past week. On a one-month basis, the Bio-techne price has risen by 27.0%. For investors holdi...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of BIO-TECHNE EPS forecast chart

Profile Summary

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

Directors

Last Annual
June 30th, 2021
Last Interim
September 30th, 2021
Incorporated
July 17th, 1981
Public Since
February 9th, 1989
No. of Shareholders
55,000
No. of Employees
2,600
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
39,295,289

TECH Share Price Performance

FAQ

Or unlock with your email

Or unlock with your email